Company Encyclopedia
View More
name
China Resources Related
CP20025.HK
News
View More

CR Sanjiu: CHINARES PHARMA's pediatric tranquilizer and brain supplement granules have received implied approval for clinical trials

China Resources Pharmaceutical announced that its subsidiary, CR Sanjiu, has obtained implied permission for clinical trials of its pediatric calming and brain-nourishing granules. This product was jointly developed by CR Sanjiu, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen Institute for Drug Inspection and Research, and Shenzhen Traditional Chinese Medicine Manufacturing Innovation Center. It is classified as a Category 1.1 new drug in traditional Chinese medicine, intended for children with tic disorders due to spleen deficiency and phlegm accumulation, as well as wind-phlegm disturbance. The company expects that obtaining this implied permission for clinical trials will help further enrich its product line and enhance the market competitiveness of its products

AASTOCKS·
SZ
000999
-1.22%
HK
03320
-1.43%
AASTOCKS·
SZ
000999
-1.22%
HK
03320
-1.43%

Daiwa downgraded the target price for CHINA RES BEER to 36 yuan and reiterated the "Buy" rating

Daiwa published a research report, reiterating its "Buy" rating on CHINA RES BEER, but lowering the target price from HKD 38 to HKD 36. Daiwa pointed out that CHINA RES BEER is catering to instant retail and developing new flavors to adapt to the changes in Chinese young consumers. Although the expansion of average selling prices and profit margins may slow down, Daiwa remains optimistic about its execution capabilities and strategic flexibility

AASTOCKS·
HK
00291
-0.07%
AASTOCKS·
HK
00291
-0.07%

"Large Banks" Huayan: Domestic real estate is in a policy vacuum period, optimistic about CHINA RES LAND, C&D INTL GROUP, and SEAZEN

"Large Banks" Huayan: Domestic real estate is in a policy vacuum period, optimistic about CHINA RES LAND, C&D INTL GROUP, and SEAZEN

AASTOCKS·
HK
01030
0.00%
HK
02925
0.00%
HK
01109
-1.15%
AASTOCKS·
HK
01030
0.00%
HK
02925
0.00%
HK
01109
-1.15%

CHINA RES MIXC opened lower by 7.9% due to a 9.6% discount on the rights issue from its parent company

CHINA RES MIXC experienced a nearly 10% discount in its placement due to its parent company CHINA RES LAND, opening down 7.85% this morning, currently reported at HKD 42.5, with a trading volume of 49.6876 million shares, involving a capital of HKD 2.072 billion. CHINA RES LAND placed 49.5 million shares of CHINA RES MIXC, accounting for approximately 2.17% of the total issued shares, at a price of HKD 41.7 per share, representing a discount of about 9.58%. The expected net amount is approximately HKD 2.061 billion, to be used for land acquisition, development costs, and operating funds

AASTOCKS·
HK
02925
0.00%
HK
01109
-1.15%
HK
01209
-1.09%
AASTOCKS·
HK
02925
0.00%
HK
01109
-1.15%
HK
01209
-1.09%

The "Hong Kong Building" New World Yuen Long South Phase 1 project has completed the supplementary land premium and will provide approximately 700 units

New World Development and China Resources Land have completed the premium payment for the Yuen Long South Phase 1 project, which will commence construction within this year, providing approximately 700 units. A spokesperson stated that the group has a land reserve of 15 million square feet, with many located in prime areas within the Northern Metropolis. The group will continue to accelerate the release of agricultural land value and capital recovery through various means, and will actively introduce strategic partners to further enhance overall development potential

AASTOCKS·
HK
00017
-1.88%
HK
02925
0.00%
HK
01109
-1.15%
AASTOCKS·
HK
00017
-1.88%
HK
02925
0.00%
HK
01109
-1.15%
Posts
View More

$CHINA RES BEER(00291.HK) Overall, China Resources Beer's performance in 24H2 is in line with expectations under low forecasts. Although the story of premiumization driving ton price increases is stil...

  • 0